col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


35 Ergebisse       Seite 1

 [1] 
Springer Science and Business Media LLC: Cell Death and Disease
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Apr―11 Research progress of post-acute sequelae after SARS-CoV-2 infection Taiwei Jiao, Yuling Huang, Haiyan Sun, Lina Yang
2 [GO] 2024―Feb―14 Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers François-Xavier Danlos, Claudia Grajeda-Iglesias, Sylvère Durand, Allan Sauvat, Mathilde Roumier, Delphine Cantin, et al. (+34)
3 [GO] 2024―Jan―30 Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivo Stefanie M. Bader, James P. Cooney, Reet Bhandari, Liana Mackiewicz, Merle Dayton, Dylan Sheerin, et al. (+6)
4 [GO] 2023―Sep―06 Immune landscape and redox imbalance during neurological disorders in COVID-19 Abhimanyu Thakur, Vartika Sharma, Sera Averbek, Lifan Liang, Nirali Pandya, Gaurav Kumar, et al. (+2)
5 [GO] 2023―Jun―30 SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors Yang Yang, Gaosi Xu
6 [GO] 2023―Apr―29 Perturbation of the host cell Ca2+ homeostasis and ER-mitochondria contact sites by the SARS-CoV-2 structural proteins E and M Elena Poggio, Francesca Vallese, Andreas J. W. Hartel, Travis J. Morgenstern, Scott A. Kanner, Oliver Rauh, et al. (+7)
7 [GO] 2023―Apr―22 Novel insight into the underlying dysregulation mechanisms of immune cell-to-cell communication by analyzing multitissue single-cell atlas of two COVID-19 patients Shijie Qin, Xiaohong Yao, Weiwei Li, Canbiao Wang, Weijun Xu, Zhenhua Gan, et al. (+18)
8 [GO] 2023―Apr―19 Plasma metabolomic characterization of SARS-CoV-2 Omicron infection Xue Li, Yimeng Liu, Guiying Xu, Yi Xie, Ximo Wang, Junping Wu, Huaiyong Chen
9 [GO] 2023―Feb―01 SARS-CoV-2 infection induces persistent adipose tissue damage in aged golden Syrian hamsters Gemma Bogard, Johanna Barthelemy, Aline Hantute-Ghesquier, Valentin Sencio, Patricia Brito-Rodrigues, Karin Séron, et al. (+7)
10 [GO] 2023―Jan―21 Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy Pavlina Spiliopoulou, Helena J. Janse van Rensburg, Lisa Avery, Vathany Kulasingam, Albiruni Razak, Philippe Bedard, et al. (+11)
11 [GO] 2022―Okt―03 Live and let die: signaling AKTivation and UPRegulation dynamics in SARS-CoVs infection and cancer Mariana Suaya, Gonzalo Manuel Sánchez, Antonella Vila, Analía Amante, María Cotarelo, Mercedes García Carrillo, Matías Blaustein
12 [GO] 2022―Aug―27 Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients Sonia André, Marne Azarias da Silva, Morgane Picard, Aurélie Alleaume-Buteau, Lucy Kundura, Renaud Cezar, et al. (+21)
13 [GO] 2022―Aug―06 USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING Rebekka Karlowitz, Megan L. Stanifer, Jens Roedig, Geoffroy Andrieux, Denisa Bojkova, Marco Bechtel, et al. (+7)
14 [GO] 2022―Mai―25 Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants Daniela Iaconis, Licia Bordi, Giulia Matusali, Carmine Talarico, Candida Manelfi, Maria Candida Cesta, et al. (+17)
15 [GO] 2022―Mai―14 Sex differences in global metabolomic profiles of COVID-19 patients Rocio Diaz Escarcega, Pedram Honarpisheh, Gabriela Delevati Colpo, Hilda W. Ahnstedt, Lucy Couture, Shivanki Juneja, et al. (+9)
16 [GO] 2022―Mrz―14 Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge Hongwei Li, Xue Li, Qian Wu, Xing Wang, Zhonghua Qin, Yaguo Wang, et al. (+4)
17 [GO] 2021―Okt―29 Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients Andrea Sacconi, Claudia De Vitis, Luisa de Latouliere, Simona di Martino, Francesca De Nicola, Frauke Goeman, et al. (+21)
18 [GO] 2021―Aug―12 Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome Francesco Messina, Emanuela Giombini, Chiara Montaldo, Ashish Arunkumar Sharma, Antonio Zoccoli, Rafick-Pierre Sekaly, et al. (+6)
19 [GO] 2021―Aug―05 Low level of plasminogen increases risk for mortality in COVID-19 patients David Della-Morte, Francesca Pacifici, Camillo Ricordi, Renato Massoud, Valentina Rovella, Stefania Proietti, et al. (+5)
20 [GO] 2021―Aug―03 Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia Alessandro Mauriello, Manuel Scimeca, Ivano Amelio, Renato Massoud, Antonio Novelli, Francesca Di Lorenzo, et al. (+9)
21 [GO] 2021―Jul―23 RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes Yuting Meng, Qiong Zhang, Kaihang Wang, Xujun Zhang, Rongwei Yang, Kefan Bi, et al. (+2)
22 [GO] 2021―Mai―25 Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery Kaimin Mao, Qi Tan, Yanling Ma, Sufei Wang, Hua Zhong, Yuhan Liao, et al. (+8)
23 [GO] 2021―Mrz―24 Inhibition of HECT E3 ligases as potential therapy for COVID-19 Giuseppe Novelli, Jing Liu, Michela Biancolella, Tonino Alonzi, Antonio Novelli, J. J. Patten, et al. (+34)
24 [GO] 2021―Mrz―12 Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis Roberta Nardacci, Francesca Colavita, Concetta Castilletti, Daniele Lapa, Giulia Matusali, Silvia Meschi, et al. (+7)
25 [GO] 2021―Mrz―11 Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers François-Xavier Danlos, Claudia Grajeda-Iglesias, Sylvère Durand, Allan Sauvat, Mathilde Roumier, Delphine Cantin, et al. (+34)
26 [GO] 2021―Jan―07 SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype Dario Bongiovanni, Melissa Klug, Olga Lazareva, Simon Weidlich, Marina Biasi, Simona Ursu, et al. (+10)
27 [GO] 2020―Dez―08 A cross-talk between epithelium and endothelium mediates human alveolar-capillary injury during SARS-CoV-2 infection Peng Wang, Ronghua Luo, Min Zhang, Yaqing Wang, Tianzhang Song, Tingting Tao, et al. (+7)
28 [GO] 2020―Nov―06 Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients Roberta Angioni, Ricardo Sánchez-Rodríguez, Fabio Munari, Nicole Bertoldi, Diletta Arcidiacono, Silvia Cavinato, et al. (+6)
29 [GO] 2020―Okt―27 Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome Alessandra Sacchi, Germana Grassi, Veronica Bordoni, Patrizia Lorenzini, Eleonora Cimini, Rita Casetti, et al. (+15)
30 [GO] 2020―Sep―24 COVID19: an announced pandemic Sara Platto, Tongtong Xue, Ernesto Carafoli
31 [GO] 2020―Aug―19 On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2 Allan Sauvat, Fabiola Ciccosanti, Francesca Colavita, Martina Di Rienzo, Concetta Castilletti, Maria Rosaria Capobianchi, et al. (+5)
32 [GO] 2020―Jul―08 BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic? Abhibhav Sharma, Saurabh Kumar Sharma, Yufang Shi, Enrico Bucci, Ernesto Carafoli, Gerry Melino, et al. (+2)
33 [GO] 2020―Jul―08 Is hydroxychloroquine beneficial for COVID-19 patients? Xing Li, Ying Wang, Patrizia Agostinis, Arnold Rabson, Gerry Melino, Ernesto Carafoli, et al. (+2)
34 [GO] 2020―Jun―08 COVID-19 infection: the China and Italy perspectives Jun Chen, Hongzhou Lu, Gerry Melino, Stefania Boccia, Mauro Piacentini, Walter Ricciardi, et al. (+3)
35 [GO] 2020―Jun―08 The inhibition of IL-2/IL-2R gives rise to CD8+ T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia Hongbo Shi, Wenjing Wang, Jiming Yin, Yabo Ouyang, Lijun Pang, Yingmei Feng, et al. (+5)
 [1] 

35 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec